Victory Capital Management Inc Alkermes Plc. Transaction History
Victory Capital Management Inc
- $99 Billion
- Q3 2024
A detailed history of Victory Capital Management Inc transactions in Alkermes Plc. stock. As of the latest transaction made, Victory Capital Management Inc holds 136,282 shares of ALKS stock, worth $4.27 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,282
Previous 115,061
18.44%
Holding current value
$4.27 Million
Previous $2.77 Million
37.59%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding ALKS
# of Institutions
362Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$911 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$594 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$407 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$396 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$288 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $5.14B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...